Copyright
©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 28, 2005; 11(4): 482-487
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study
Nikolaos K. Gatselis, Sarah P. Georgiadou, Kalliopi Zachou, Christos Liaskos, Georgios N. Dalekos, Department of Internal Medicine, Research Laboratory of Internal Medicine, Medical School, University of Thessaly Larissa, Greece
Nikolaos Tassopoulos, Department of Internal Medicine, Western Attica Hospital, Athens, Greece
Kalliopi Zachou, Georgios N. Dalekos, Academic Liver Unit, Department of Internal Medicine, Medical School, University of Thessaly Larissa, Greece
Angelos Hatzakis, Department of Hygiene and Epidemiology, National Retrovirus Reference Center, Athens University Medical School, Athens, Greece
Author contributions: All authors contributed equally to the work.
Correspondence to: Georgios N. Dalekos, M.D., Associate Professor of Medicine, Academic Liver Unit and Research Laboratory of Internal Medicine, Medical School, University of Thessaly, Papakiriazi 22 str, 41222 Larissa, Greece. dalekos@med.uth.gr
Telephone: +30-2410-565251 Fax: +30-2410-565250
Received: May 25, 2004
Revised: May 28, 2004
Accepted: June 18, 2004
Published online: January 28, 2005
Revised: May 28, 2004
Accepted: June 18, 2004
Published online: January 28, 2005
Core Tip